The first JSE-listed company to have links to the fast-growing cannabis industry, estimated to be as large as R27bn, Labat Africa has made a number of acquisitions to help it in its new venture. It dumped its fuel interests recently and expects cannabis to make up almost all of its revenue by 2021. Labat Pharmaceuticals CEO Mike Stringer talks to Business Day about the technical aspects of the industry and its plans to expand into the cannabis market.

What regulatory environment does Labat Africa find itself in, and how are you planning to navigate the move into cannabis? ..

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.